• Title/Summary/Keyword: Primary Radiation

Search Result 934, Processing Time 0.025 seconds

Some Measurements of Scattered Radiation from Various Radiation Shielding Materials (방사선(放射線) 차폐물질(遮蔽物質)에서 발생(發生)하는 산란선(散亂線)의 측정(測定))

  • Kim, Chang-Kyun
    • Journal of radiological science and technology
    • /
    • v.4 no.1
    • /
    • pp.15-22
    • /
    • 1981
  • Half value layer(radiation energy) of $90^{\circ}$ scattered radiation from various radiation shielding materials was measured at 1 m distance from the central ray of the primary beam. Scattered radiation was measured from 100 to 200 kVp for 0-2.0mm Cu+1.0mm Al added filter in the primary beam for a deep therapeutic unit, the obtained results were as follows: 1. The ratio of scattered radiation to primary radiation was increased by using lighter filter. 2. The ratio of scattered radiation to primary radiation was decreased by using heavier filter. 3. The ratio of scattered radiation to primary radiation was independent of tube voltage. 4. The scattered radiation of high energy was produced, when the effective atomic number and density of shielding material were high.

  • PDF

Re-irradiation of recurrent esophageal cancer after primary definitive radiotherapy

  • Kim, Young Suk;Lee, Chang Geol;Kim, Kyung Hwan;Kim, Taehyung;Lee, Joohwan;Cho, Yona;Koom, Woong Sub
    • Radiation Oncology Journal
    • /
    • v.30 no.4
    • /
    • pp.182-188
    • /
    • 2012
  • Purpose: For recurrent esophageal cancer after primary definitive radiotherapy, no general treatment guidelines are available. We evaluated the toxicities and clinical outcomes of re-irradiation (re-RT) for recurrent esophageal cancer. Materials and Methods: We analyzed 10 patients with recurrent esophageal cancer treated with re-RT after primary definitive radiotherapy. The median time interval between primary radiotherapy and re-RT was 15.6 months (range, 4.8 to 36.4 months). The total dose of primary radiotherapy was a median of 50.4 Gy (range, 50.4 to 63.0 Gy). The total dose of re-RT was a median of 46.5 Gy (range, 44.0 to 50.4 Gy). Results: The median follow-up period was 4.9 months (range, 2.6 to 11.4 months). The tumor response at 3 months after the end of re-RT was complete response (n = 2), partial response (n = 1), stable disease (n = 2), and progressive disease (n = 5). Grade 5 tracheoesophageal fistula developed in three patients. The time interval between primary radiotherapy and re-RT was less than 12 months in two of these three patients. Late toxicities included grade 1 dysphagia (n = 1). Conclusion: Re-RT of recurrent esophageal cancer after primary radiotherapy can cause severe toxicity.

Primary Squamous Cell Carcinoma of the Parotid Gland (원발성 이하선 편평상피세포암종)

  • Lee Sang-Wook;Kim Gwi-Eon;Park Cheong-Soo;Park Won;Lee Chang-Geol;Keum Ki-Chang;Lim Ji-Hoon;Yang Wook-Ick;Suh Chang-Ok
    • Korean Journal of Head & Neck Oncology
    • /
    • v.13 no.2
    • /
    • pp.228-234
    • /
    • 1997
  • Squamous cell carcinoma originating in the parotid gland has rare occurrence. The primary squamous cell carcinoma of the parotid gland comprise about 0.3% and 9.8% of all parotid malignant tumor. We investigated the clinical behavior and treatment outcome of patients with primary squamous cell carcinoma of the parotid gland. We reviewed all cases of possible primary squamous cell carcinoma of the parotid gland treated at Yonsei Cancer Center, Seoul, Korea, from 1981 through 1995. A total of 128 had primary parotid malignancy. Metastatic squamous cell carcinoma and mucoepidermoid carcinoma were excluded in this study. Ten cases of primary squamous cell carcinoma of the parotid gland were identified. 6 cases of them are men & 4 cases are women. The age of patients ranged from 31 to 68 years with median age of 55 years. On physical examination, 5 cases had palpated cervical neck node and 6 cases had facial nerve palsy. Staging was done according to the current guidelines established by the American Joint Committee on Cancer (1992). Two cases were stage I, 1 in stage III, and 7 in stage IV. Six cases were performed operation and postoperative radiation therapy. Four cases were treated by curative radiation therapy, dose of more than 65 Gy on parotid gland region. The 5 year actual survival rate and the 5 year disease free survival rate were 30.8%, and 40.0%. Initial complete response rate was 70% for all patients. Local failure were occurred 3 of 7 patients with local controlled cases, failure sites were primary site, ipsilateral cervical neck node, contralateral supraclavicular node. Most recurrences developed within 1 year of initial treatment. Distant metastasis was appeared 2 of 3 patients who did not achieved local control. Primary squamous cell carcinoma of the parotid gland occured infrequently. A retrospective study at the Yonsei Cancer Center indicates incidence of 7.8%. At diagnosis, advanced stage, neck node presentation, facial nerve paralysis were associated with a poor prognosis. These results may suggested that radical surgical excision may be treatment of choice and that planned postoperative radiotherapy may be bendicial for reducing locoregional recurrence rates.

  • PDF

A Study on Structural Shielding Design of Afterloading Therapy Room (강내치료실 차폐에 대한 고찰)

  • Yun, Suk-Rok;Kim, Myung-Ho;Shin, Dong-Oh
    • The Journal of Korean Society for Radiation Therapy
    • /
    • v.2 no.1
    • /
    • pp.31-40
    • /
    • 1987
  • In the case of designing a high dose rate remote controlled afterloading treatment room with existing hospital facilities. We must construct the effective protective barriers so as to reduce the primary and scattered radiation up to the maximum permissible dose level. It is difficult to reinforce the barrier thickness of the shielding requirements because of the limited space and the problem of the existing building structure at the surrounding area. Therefore we can reduce the intensity of primary radiation to the required degree at the location of interest with installing the appropriate I shaped Pb barriers between the radiation source and the shielding wall of the concrete. As a result, it was possible to reduce the intensity of the primary radiation below the M.P.D level by using additional Pb barriers instead of increasing thickness of concrete wall.

  • PDF

Stereotactic body radiation therapy for liver oligo-recurrence and oligo-progression from various tumors

  • Cha, Yu Jin;Kim, Mi-Sook;Jang, Won-Il;Seo, Young Seok;Cho, Chul Koo;Yoo, Hyung Jun;Paik, Eun Kyung
    • Radiation Oncology Journal
    • /
    • v.35 no.2
    • /
    • pp.172-179
    • /
    • 2017
  • Purpose: To evaluate the outcomes of stereotactic body radiation therapy (SBRT) for patients with liver oligo-recurrence and oligo-progression from various primary tumors. Materials and Methods: Between 2002 and 2013, 72 patients with liver oligo-recurrence (oligo-metastasis with a controlled primary tumor) and oligo-progression (contradictory progression of a few sites of disease despite an overall tumor burden response to therapy) underwent SBRT. Of these, 9 and 8 patients with uncontrollable distant metastases and patients immediate loss to follow-up, respectively, were excluded. The total planning target volume was used to select the SBRT dose (median, 48 Gy; range, 30 to 60 Gy, 3-4 fractions). Toxicity was evaluated using the Common Toxicity Criteria for Adverse Events v4.0. Results: We evaluated 55 patients (77 lesions) treated with SBRT for liver metastases. All patients had controlled primary lesions, and 28 patients had stable lesions at another site (oligo-progression). The most common primary site was the colon (36 patients), followed by the stomach (6 patients) and other sites (13 patients). The 2-year local control and progression-free survival rates were 68% and 22%, respectively. The 2- and 5-year overall survival rates were 56% and 20%, respectively. The most common adverse events were grade 1-2 fatigue, nausea, and vomiting; no grade ${\geq}3$ toxicities were observed. Univariate analysis revealed that oligo-progression associated with poor survival. Conclusion: SBRT for liver oligo-recurrence and oligo-progression appears safe, with similar local control rates. For liver oligo-progression, criteria are needed to select patients in whom improved overall survival can be expected through SBRT.

Simple Calculation Method as a Supplementary Radiation Safety Assessment for Facility with Radiation Generator

  • Kim, Sang-Tae
    • International Journal of Contents
    • /
    • v.14 no.4
    • /
    • pp.65-69
    • /
    • 2018
  • The objective of this study was to conduct a radiation shielding analysis for the facility equipped with radiation generator. The analysis was carried out in two aspects. First, from the aspect of the effect caused by primary and leakage radiation. Second, effect of scattered radiation was evaluated by applying a simple calculation method based on a scattering rate concept since effect of scattered radiation is significantly important at maze entrance of the radiation facility. The calculated results obtained using the simple method were compared to the results calculated using Geant4 code and the measured values. The results calculated by the suggested method indicate that slight error exists in a radiation shielding analysis done at the maze entrance comparing to other two results, while the results evaluated at the outside of the maze entrance door are relatively consistent with other values.

Prediction of Seasonal Variations on Primary Production Efficiency in a Eutrophicated Bay (부영양화해역의 내부생산효율에 대한 계절변동예측)

  • 이인철
    • Journal of Ocean Engineering and Technology
    • /
    • v.15 no.4
    • /
    • pp.53-59
    • /
    • 2001
  • The Primary Production of phytoplanktons produces organic matter in high concentration in eutrophicated Hakata Bay, Japan, even during the winter season in spite of low water temperature. Phytoplanktons are considered to have any biological capabilities to keep activities of photosynthesis under the unfavorable conditions, and this affects water quality of the bay. In this study, seasonal variations in primary production efficiency were predicted by using a simple box-type ecosystem model, which introduced the concept of efficiency for absorption of solar radiation energy in relation to growth of phytoplanktons under the low solar radiation intensity. According to the simulation result of primary production, it was organic pollution comes from dissolved organic carbon (DOC) throughout the year, DOC of which is originated from the primary production of phytoplanktons on biological response of the seasonal variation of ambient conditions.

  • PDF

Primary Malignant Melanoma of the Cervical Spinal Cord -Case Report- (경추 척수의 원발성 흑색종양)

  • Kim, Chul-Yong;Choi, Myung-Sun
    • Radiation Oncology Journal
    • /
    • v.5 no.1
    • /
    • pp.43-47
    • /
    • 1987
  • Primary malignant melanom of the spinal cord is extremely rare. The best treatment appears to be total surgical excision, when possible and postoperative irradiation, but the value of radiotherapy is unknown because the number of cases that have been irradiated postoperatively is small. The 2-year survival rate for primary malignant melanoma of the spinal cord is usually less than $16\%$ and most patients died within 1 year. The prognosis of this tumor is poor.

  • PDF

Primary Malignant Melanoma of the Vagina: A Case Report (질의 원발성 악성 흑색종: 증례보고)

  • Jang Ji-Young;Kim Do-Kang;Lee Eun-Hee;Kim Jun-Sang
    • Radiation Oncology Journal
    • /
    • v.21 no.3
    • /
    • pp.245-249
    • /
    • 2003
  • A primary malignant melanoma of the vagina is a very rare gynecological malignant tumor. Its clinical behavior is more aggressive than that of cutaneous and vulvar melanomas. We present a case of a large sized primary melanoma of the lower third of the vagina, with a cervical lesion, in a 58-year-old postmenopausal woman. The patient was treated with conventional external radiation therapy and intracavitary radiotherapy (ICR), without surgical treatment. Although the primary lesion showed a partial response, the patient died of extensive metastases, which were found 4.5 months after the initial diagnosis. We suggest that shortening the treatment period, such as hypofractionated radiation therapy and surgical removal, and various systemic therapies for preventing early distant metastasis, are appropriate treatments for a primary malignant melanoma of the vagina, with a large tumor size.

Patterns of recurrence after radiation therapy for high-risk neuroblastoma

  • Jo, Ji Hwan;Ahn, Seung Do;Koh, Minji;Kim, Jong Hoon;Lee, Sang-wook;Song, Si Yeol;Yoon, Sang Min;Kim, Young Seok;Kim, Su Ssan;Park, Jin-hong;Jung, Jinhong;Choi, Eun Kyung
    • Radiation Oncology Journal
    • /
    • v.37 no.3
    • /
    • pp.224-231
    • /
    • 2019
  • Purpose: To investigate the patterns of recurrence in patients with neuroblastoma treated with radiation therapy to the primary tumor site. Materials and Methods: We retrospectively analyzed patients with high-risk neuroblastoma managed with definitive treatment with radiation therapy to the primary tumor site between January 2003 and June 2017. These patients underwent three-dimensional conformal radiation therapy or intensity-modulated radiation therapy. A total of 14-36 Gy was delivered to the planning target volume, which included the primary tumor bed and the selected metastatic site. The disease stage was determined according to the International Neuroblastoma Staging System (INSS). We evaluated the recurrence pattern (i.e., local or systemic), progression-free survival, and overall survival. Results: A total of 40 patients with high-risk neuroblastoma were included in this study. The median patient age was 4 years (range, 1 to 11 years). Thirty patients (75%) had INSS stage 4 neuroblastoma. At the median follow-up of 58 months, there were 6 cases of local recurrence and 10 cases of systemic recurrence. Among the 6 local failure cases, 4 relapsed adjacent to the radiation field. The other 2 relapsed in the radiation field (i.e., para-aortic and retroperitoneal areas). The main sites of distant metastasis were the bone, lymph nodes, and bone marrow. The 5-year progression-free survival was 70.9% and the 5-year overall survival was 74.3%. Conclusion: Radiation therapy directed at the primary tumor site provides good local control. It seems to be adequate for disease control in patients with high-risk neuroblastoma after chemotherapy and surgical resection.